FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044527195> ?p ?o ?g. }

• W2044527195 endingPage "988" @default.
• W2044527195 startingPage "982" @default.
• W2044527195 abstract "Background Recent evidence has shown that several chemokines—including those involved in angiogenesis—have been implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF) and sarcoidosis. We speculated that these differences could be attributed to distinct angiogenic and angiostatic profiles. This hypothesis was investigated by estimating the levels of three angiogenic chemokines (growth-related gene [GRO]-α, epithelial neutrophil-activating protein [ENA]-78, and interleukin [IL]-8), and three angiostatic chemokines (monokine induced by interferon (IFN)-γ [MIG], IFN-γ–inducible protein [IP]-10, and IFN-γ–inducible T-cell α chemoattractant) in serum and BAL fluid (BALF). Methods We studied prospectively 20 patients with sarcoidosis (median age, 46 years; range, 25 to 65 years), 20 patients with IPF (median age, 68 years; range, 40 to 75 years), and 10 normal subjects (median age, 39 years; range, 26 to 60 years). Results The GRO-a serum and BALF levels of IPF patients were found significantly increased in comparison with healthy subjects (799 pg/mL vs 294 pg/mL [p = 0.022] and 1,827 pg/mL vs 94 pg/mL [p < 0.001], respectively) and sarcoidosis patients (799 pg/mL vs 44 pg/mL [p < 0.001] and 1,827 pg/mL vs 214 pg/mL [p < 0.001], respectively). Moreover, ENA-78 and IL-8 BALF levels in IPF patients were significantly higher compared with sarcoidosis patients (191 pg/mL vs 30 pg/mL [p < 0.001] and 640 pg/mL vs 94 pg/mL [p = 0.03], respectively). MIG serum levels in IPF patients were found significantly upregulated in comparison with sarcoidosis patients and healthy control subjects. However, MIG and IP-10 BALF levels (1,136 pg/mL vs 66 pg/mL [p < 0.001] and 112 pg/mL vs 56 pg/mL [p = 0.037], respectively) were significantly higher in sarcoidosis patients compared with IPF patients. Conclusions Our data suggest distinct angiogenic profiles between IPF and sarcoidosis, indicating a potential different role of CXC chemokines in the local immunologic response in IPF and pulmonary sarcoidosis. Recent evidence has shown that several chemokines—including those involved in angiogenesis—have been implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF) and sarcoidosis. We speculated that these differences could be attributed to distinct angiogenic and angiostatic profiles. This hypothesis was investigated by estimating the levels of three angiogenic chemokines (growth-related gene [GRO]-α, epithelial neutrophil-activating protein [ENA]-78, and interleukin [IL]-8), and three angiostatic chemokines (monokine induced by interferon (IFN)-γ [MIG], IFN-γ–inducible protein [IP]-10, and IFN-γ–inducible T-cell α chemoattractant) in serum and BAL fluid (BALF). We studied prospectively 20 patients with sarcoidosis (median age, 46 years; range, 25 to 65 years), 20 patients with IPF (median age, 68 years; range, 40 to 75 years), and 10 normal subjects (median age, 39 years; range, 26 to 60 years). The GRO-a serum and BALF levels of IPF patients were found significantly increased in comparison with healthy subjects (799 pg/mL vs 294 pg/mL [p = 0.022] and 1,827 pg/mL vs 94 pg/mL [p < 0.001], respectively) and sarcoidosis patients (799 pg/mL vs 44 pg/mL [p < 0.001] and 1,827 pg/mL vs 214 pg/mL [p < 0.001], respectively). Moreover, ENA-78 and IL-8 BALF levels in IPF patients were significantly higher compared with sarcoidosis patients (191 pg/mL vs 30 pg/mL [p < 0.001] and 640 pg/mL vs 94 pg/mL [p = 0.03], respectively). MIG serum levels in IPF patients were found significantly upregulated in comparison with sarcoidosis patients and healthy control subjects. However, MIG and IP-10 BALF levels (1,136 pg/mL vs 66 pg/mL [p < 0.001] and 112 pg/mL vs 56 pg/mL [p = 0.037], respectively) were significantly higher in sarcoidosis patients compared with IPF patients. Our data suggest distinct angiogenic profiles between IPF and sarcoidosis, indicating a potential different role of CXC chemokines in the local immunologic response in IPF and pulmonary sarcoidosis." @default.
• W2044527195 created "2016-06-24" @default.
• W2044527195 creator A5000811370 @default.
• W2044527195 creator A5003135356 @default.
• W2044527195 creator A5022894179 @default.
• W2044527195 creator A5033325682 @default.
• W2044527195 creator A5034160843 @default.
• W2044527195 creator A5042145544 @default.
• W2044527195 creator A5057349773 @default.
• W2044527195 creator A5062188933 @default.
• W2044527195 creator A5073043130 @default.
• W2044527195 creator A5088346886 @default.
• W2044527195 date "2006-10-01" @default.
• W2044527195 modified "2023-10-18" @default.
• W2044527195 title "Different Angiogenic Activity in Pulmonary Sarcoidosis and Idiopathic Pulmonary Fibrosis" @default.
• W2044527195 cites W1922000778 @default.
• W2044527195 cites W1962154935 @default.
• W2044527195 cites W1975096058 @default.
• W2044527195 cites W1978923969 @default.
• W2044527195 cites W1985264526 @default.
• W2044527195 cites W1987934540 @default.
• W2044527195 cites W1988267370 @default.
• W2044527195 cites W2005245427 @default.
• W2044527195 cites W2005659566 @default.
• W2044527195 cites W2012471161 @default.
• W2044527195 cites W2024705279 @default.
• W2044527195 cites W2055916655 @default.
• W2044527195 cites W2083288984 @default.
• W2044527195 cites W2097937633 @default.
• W2044527195 cites W2101602651 @default.
• W2044527195 cites W2104216442 @default.
• W2044527195 cites W2110238749 @default.
• W2044527195 cites W2110749959 @default.
• W2044527195 cites W2129416247 @default.
• W2044527195 cites W2130409324 @default.
• W2044527195 cites W2130794462 @default.
• W2044527195 cites W2143753556 @default.
• W2044527195 cites W2152726130 @default.
• W2044527195 cites W2416914730 @default.
• W2044527195 cites W2604596332 @default.
• W2044527195 doi "https://doi.org/10.1378/chest.130.4.982" @default.
• W2044527195 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17035428" @default.
• W2044527195 hasPublicationYear "2006" @default.
• W2044527195 type Work @default.
• W2044527195 sameAs 2044527195 @default.
• W2044527195 citedByCount "73" @default.
• W2044527195 countsByYear W20445271952012 @default.
• W2044527195 countsByYear W20445271952013 @default.
• W2044527195 countsByYear W20445271952014 @default.
• W2044527195 countsByYear W20445271952015 @default.
• W2044527195 countsByYear W20445271952016 @default.
• W2044527195 countsByYear W20445271952018 @default.
• W2044527195 countsByYear W20445271952019 @default.
• W2044527195 countsByYear W20445271952020 @default.
• W2044527195 countsByYear W20445271952021 @default.
• W2044527195 countsByYear W20445271952022 @default.
• W2044527195 crossrefType "journal-article" @default.
• W2044527195 hasAuthorship W2044527195A5000811370 @default.
• W2044527195 hasAuthorship W2044527195A5003135356 @default.
• W2044527195 hasAuthorship W2044527195A5022894179 @default.
• W2044527195 hasAuthorship W2044527195A5033325682 @default.
• W2044527195 hasAuthorship W2044527195A5034160843 @default.
• W2044527195 hasAuthorship W2044527195A5042145544 @default.
• W2044527195 hasAuthorship W2044527195A5057349773 @default.
• W2044527195 hasAuthorship W2044527195A5062188933 @default.
• W2044527195 hasAuthorship W2044527195A5073043130 @default.
• W2044527195 hasAuthorship W2044527195A5088346886 @default.
• W2044527195 hasConcept C126322002 @default.
• W2044527195 hasConcept C13373296 @default.
• W2044527195 hasConcept C142724271 @default.
• W2044527195 hasConcept C203014093 @default.
• W2044527195 hasConcept C2776914184 @default.
• W2044527195 hasConcept C2777714996 @default.
• W2044527195 hasConcept C2777961210 @default.
• W2044527195 hasConcept C2778341716 @default.
• W2044527195 hasConcept C2778690821 @default.
• W2044527195 hasConcept C2779603739 @default.
• W2044527195 hasConcept C2780394083 @default.
• W2044527195 hasConcept C2780559512 @default.
• W2044527195 hasConcept C2780942790 @default.
• W2044527195 hasConcept C2781244666 @default.
• W2044527195 hasConcept C2781301800 @default.
• W2044527195 hasConcept C68324877 @default.
• W2044527195 hasConcept C71924100 @default.
• W2044527195 hasConcept C90924648 @default.
• W2044527195 hasConceptScore W2044527195C126322002 @default.
• W2044527195 hasConceptScore W2044527195C13373296 @default.
• W2044527195 hasConceptScore W2044527195C142724271 @default.
• W2044527195 hasConceptScore W2044527195C203014093 @default.
• W2044527195 hasConceptScore W2044527195C2776914184 @default.
• W2044527195 hasConceptScore W2044527195C2777714996 @default.
• W2044527195 hasConceptScore W2044527195C2777961210 @default.
• W2044527195 hasConceptScore W2044527195C2778341716 @default.
• W2044527195 hasConceptScore W2044527195C2778690821 @default.
• W2044527195 hasConceptScore W2044527195C2779603739 @default.
• W2044527195 hasConceptScore W2044527195C2780394083 @default.
• W2044527195 hasConceptScore W2044527195C2780559512 @default.
• W2044527195 hasConceptScore W2044527195C2780942790 @default.

• next